Literature DB >> 19767017

Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience.

Michele Musci1, Yuguo Weng, Michael Hübler, Aref Amiri, Miralem Pasic, Susanne Kosky, Julia Stein, Henryk Siniawski, Roland Hetzer.   

Abstract

OBJECTIVE: We compared early and long-term results of cryopreserved homograft aortic root replacement in native valve endocarditis or prosthetic valve endocarditis associated with periannular abscess.
METHODS: Between May 1986 and December 2007, 1163 patients with endocarditis were operated upon. Of these, 221 patients (n = 185 men, median age 55 years) had homograft aortic root replacement due to 99 cases of native valve endocarditis (45%) and 122 of prosthetic valve endocarditis (55%). Perinannular abscess developed in 189 patients (86%), and aortoventricular dehiscence in 120 (63.5%) of them. Perioperative characteristics, probability of survival, freedom from recurrence, and reoperation were analyzed. Follow-up (mean 5.2 +/- 0.4 years, maximum 18.4 years) was completed in 96.8% with a total of 1127 patient-years.
RESULTS: Overall native valve endocarditis survival at 30 days and 1, 5, and 10 years was 83.8% +/- 3.7%, 76.6% +/- 4.3%, 66.5% +/- 4.9%, and 47.3% +/- 5.6%, respectively, significantly better than for patients with prosthetic valve endocarditis, who had a greater tendency toward abscess formation (P = .029). Thirty-one patients (14.0%) required reoperation either for structural valve deterioration (n = 19, 8.6%), with a greater tendency in patients aged <40 years, or for recurrent endocarditis of the homograft (n = 12, 5.4%). One-year reoperation mortality rate was 16.1% (n = 5).
CONCLUSIONS: Homograft aortic root replacement in active infective endocarditis with periannular abscess formation shows satisfactory early and long-term results with significantly better survival in native valve endocarditis than prosthetic valve endocarditis. It is associated with a low recurrence rate, although the risk of structural valve deterioration increases over time, especially in young patients, and reoperation remains a challenge. In our institution, the homograft remains the preferred valve substitute in active infective endocarditis with periannular abscess formation. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19767017     DOI: 10.1016/j.jtcvs.2009.07.026

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  40 in total

Review 1.  Molecular methods for diagnosis of infective endocarditis.

Authors:  Gorm Lisby; Ernö Gutschik; David T Durack
Journal:  Infect Dis Clin North Am       Date:  2002-06       Impact factor: 5.982

2.  Reoperation for aortic homograft failure using an Edwards Intuity valve.

Authors:  Gianluca Folesani; Giovanni Calcara; Giuseppe Minniti; Elvio Polesel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-12-15

3.  Aortic Valve Reoperation After Stentless Bioprosthesis: Short- and Long-Term Outcomes.

Authors:  Bo Yang; Himanshu J Patel; Elizabeth L Norton; Christina Debenedictus; Linda Farhat; Xiaoting Wu; Kevin He; Whitney E Hornsby; Donald S Likosky; G Michael Deeb
Journal:  Ann Thorac Surg       Date:  2018-04-03       Impact factor: 4.330

4.  Mid- to long-term outcomes of cardiovascular tissue replacements utilizing homografts harvested and stored at Japanese institutional tissue banks.

Authors:  Soichiro Kitamura; Toshikatsu Yagihara; Junjiro Kobayashi; Hiroyuki Nakajima; Koichi Toda; Tomoyuki Fujita; Hajime Ichikawa; Hitoshi Ogino; Takeshi Nakatani; Shigeki Taniguchi
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

Review 5.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

6.  Midterm Follow-up after Cryopreserved Homograft Replacement in the Aortic Position.

Authors:  Samina Park; Ho Young Hwang; Kyung-Hwan Kim; Ki-Bong Kim; Hyuk Ahn
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-02-07

7.  Repair for active infective atrioventricular valve endocarditis: 23-year single center experience.

Authors:  Michele Musci; Michael Hübler; Aref Amiri; Julia Stein; Susanne Kosky; Yuguo Weng; Miralem Pasic; Roland Hetzer
Journal:  Clin Res Cardiol       Date:  2011-06-25       Impact factor: 5.460

Review 8.  Surgical treatment for aortic periannular abscess/pseudoaneurysm caused by infective endocarditis.

Authors:  Kenji Okada; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-17

9.  Molecular methods for diagnosis of infective endocarditis.

Authors:  Annette Moter; Michele Musci; Dinah Schmiedel
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 10.  Surgical treatment of aortic valve disease.

Authors:  Tirone E David
Journal:  Nat Rev Cardiol       Date:  2013-05-14       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.